Medtronic: Managing Her Diabetes 'Runner's High'
Medtronic: Managing Her Diabetes 'Runner's High'
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / Medtronic
馬薩諸塞州北安普敦/ACCESSWIRE /2024年5月9日/美敦力
Technology helps people living with diabetes manage the highs and lows of blood sugar
技術幫助糖尿病患者控制血糖的高低水平
Jodie Snavely finds mental relaxation when she's running. And she runs a lot - nearly every day.
Jodie Snavely 在跑步時會感到精神放鬆。而且她經常跑步 —— 幾乎每天都在跑步。
Achieving that mental relaxation hasn't always been easy, however. For years, Snavely's type 1 diabetes (T1D) added stress, especially when it came to managing her blood sugar levels. She had to consider how much to eat before a long run, how much insulin to give herself, and how her levels changed during a workout.
但是，實現心理放鬆並不總是那麼容易。多年來，Snavely的1型糖尿病（T1D）增加了壓力，尤其是在控制血糖水平方面。她必須考慮在長跑之前要吃多少胰島素，要給自己攝入多少胰島素，以及在鍛鍊期間她的水平會發生怎樣的變化。
"Trying to manage all that myself felt like a lot of guesswork," recalls Snavely, 57, who today has several half-marathons under her belt. "And then after I stopped running, my blood sugar would still go up - sometimes really high."
57歲的斯納維利回憶說：“試圖自己管理所有事情就像是一場猜測，” 她今天已經參加了幾場半程馬拉松比賽。“然後在我停止跑步之後，我的血糖還會升高——有時會很高。”
What is hyperglycemia?
什麼是高血糖？
High blood sugar, called hyperglycemia, occurs in people with diabetes when there is not enough insulin to regulate the amount of glucose in the blood. This can happen for several reasons, including not taking enough insulin after a meal, fluctuating hormones during monthly menstrual cycles, stress or illness, or dawn phenomenon (when individuals experience a rise in blood sugars in the early morning). Short-term effects include frequent urination, thirst, and fatigue.
當胰島素不足以調節血液中的葡萄糖含量時，糖尿病患者就會出現高血糖，稱爲高血糖。發生這種情況可能有多種原因，包括飯後沒有攝入足夠的胰島素、月經週期中荷爾蒙的波動、壓力或疾病，或者黎明現象（當人們在清晨出現血糖升高時）。短期影響包括尿頻、口渴和疲勞。
When she experiences high blood sugar, Snavely recognizes it right away. "I feel sluggish with slight flu-like symptoms - just yucky and not as clear of mind."
當她出現高血糖時，Snavely 會立即認出血糖。“我感覺呆滯，有輕微的流感樣症狀——只是討厭，頭腦不太清醒。”
If left untreated, hyperglycemia can lead to serious health complications such as nerve damage, heart disease, kidney damage, and can even impact cognitive function.
如果不及時治療，高血糖會導致嚴重的健康併發症，例如神經損傷、心臟病、腎臟損傷，甚至會影響認知功能。
High-tech to reduce highs
高科技可以降低高點
Some people who live with type 1 diabetes use exercise to help manage high blood sugars. But advances in technology have improved diabetes management in a more predictable way, allowing individuals to track their blood sugar levels closely and make necessary adjustments to their diet and medication.
一些患有1型糖尿病的人使用運動來幫助控制高血糖。但是技術的進步以更可預測的方式改善了糖尿病的管理，使人們能夠密切跟蹤自己的血糖水平，並對飲食和藥物進行必要的調整。
Snavely relies on the newest technology to help keep highs in check: the MiniMedTM 780G system with Meal DetectionTM technology, which automatically adjusts and corrects sugar levels every five minutes. The device has been instrumental in preventing the blood sugar spikes she experienced after longer runs.
Snavely 依靠最新技術來幫助控制高點：MiniMedTM 帶膳食檢測功能的 780G 系統TM 技術，每五分鐘自動調整和校正血糖水平。該設備在防止她長時間跑步後出現的血糖飆升方面發揮了重要作用。
When she miscalculates how many carbohydrates she's eaten, the system keeps her sugar levels where she wants them. As a result, she spends less time thinking and worrying about how her diabetes is affecting her life and her runs.
當她錯誤地計算了自己吃了多少碳水化合物時，系統會將她的糖水平保持在她想要的水平。結果，她花在思考和擔心糖尿病如何影響她的生活和跑步上的時間減少了。
"My device helps me relax my mind and makes me not worry about 'Did I give myself too much insulin?' or 'Did I not give enough?'" said Snavely. "Now I don't have those spikes up and spikes down. My blood sugar levels are more even."
“我的設備可以幫助我放鬆心情，不用擔心'我給自己注射了太多胰島素嗎？'或者'我付的還不夠嗎？'”斯納維利說。“現在我沒有那些尖峯向上和向下的尖峯了。我的血糖水平更均勻。”
That peace of mind enables the mental relaxation Snavely enjoys most during long-distance runs. And all those runs keep her feeling healthy - that matters to her. Her grandfather, who also had diabetes, died at age 51. She's now 57, and plans for a long life.
這種內心的平靜使得 Snavely 在長跑中最享受的心理放鬆。所有這些跑步都能讓她保持健康——這對她來說很重要。她的祖父也患有糖尿病，在51歲時去世。她現年57歲，計劃長壽。
"I love that when I'm running, I'm keeping myself healthy for as long as I possibly can. I'm not going to let diabetes take me down."
“我喜歡跑步時儘可能長時間地保持自己的健康。我不會讓糖尿病讓我失望。”
To learn more about Medtronic, click here.
要了解有關美敦力的更多信息，請單擊此處。
Important Safety Information: MiniMed 780G System With SmartGuard Technology With Guardian 4 Sensor
The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
重要安全信息：採用 SmartGuard 技術和 Guardian 4 傳感器的 MiniMed 780G 系統
MiniMed 780G 系統旨在以可選速率持續輸送基礎胰島素，並按可選劑量給予胰島素補充劑，用於管理需要胰島素的七歲及以上人群的 1 型糖尿病，以及持續監測皮下液體中的葡萄糖水平和趨勢。MiniMed 780G 系統包含 SmartGuard 技術，可對該技術進行編程，使其根據連續血糖監測 (CGM) 傳感器的葡萄糖值自動調整胰島素輸送，當傳感器葡萄糖 (SG) 值低於或預計會降至預定義閾值以下時，可以暫停胰島素輸送。
The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.
美敦力 miNiMed 780G 系統由以下設備組成：miniMed 780G 胰島素泵、Guardian 4 發射器、Guardian 4 傳感器、One-Press serter、Accu-Chek Guide Link 血糖計和 Accu-Chek Guide 試紙。該系統需要醫療保健專業人員的處方。
The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.
Guardian 4傳感器適用於MiniMed 780G系統和Guardian 4發射器，用於監測血糖水平，以管理糖尿病。該傳感器僅供一次性使用，需要處方。Guardian 4 傳感器最多可連續使用七天。
The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
當 MiniMed 780G 在手動模式下運行時，Guardian 4 傳感器不適合直接用於調整療法。手動模式下的所有治療調整都應基於使用血糖儀獲得的測量值，而不是基於Guardian 4傳感器提供的值。Guardian 4傳感器已經過研究，獲准用於7歲及以上的患者，並且僅用於手臂插入部位。請勿在腹部或包括臀部在內的其他身體部位使用 Guardian 4 傳感器，因爲未知或不同的性能可能會導致低血糖或高血糖。
WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.
警告：請勿使用 SmartGuard 此功能適用於每天需要少於 8 個單位或大於 250 個單位的每日胰島素總量的人。在 SmartGuard 中運行所需的每日總劑量至少爲 8 個單位，但不超過 250 個單位 功能。
WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.
警告：在接受醫療保健專業人員的適當培訓之前，請勿使用 MiniMed 780G 系統。培訓對於確保安全使用MiniMed 780G系統至關重要。
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
警告：在泵處於手動模式時，請勿使用 SG 值做出治療決策，包括給予推注。當 SmartGuard 功能處於活動狀態且您不再處於手動模式時，泵會使用 SG 值（如果可用）來計算推注量。但是，如果您的症狀與 SG 值不符，請使用血壓計來確認 SG 值。當您的症狀與 SG 值不匹配時未能確認血糖水平可能會導致胰島素輸注過多或過少，從而可能導致低血糖或高血糖。
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at
對於視力或聽覺不允許識別泵信號、警報或警報的人，不建議進行泵送治療。尚未對孕婦、2型糖尿病患者或使用其他不包括胰島素的抗高血糖療法的人群進行過MiniMed 780G系統的安全性研究。有關係統的完整詳細信息，包括產品和重要的安全信息，例如與系統及其組件相關的適應症、禁忌症、警告和注意事項，請參閱相應的用戶指南
View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com.
Contact Info:
Spokesperson: Medtronic
在 3blmedia.com 上查看美敦力提供的更多多媒體和更多 ESG 故事。
聯繫信息：
發言人：美敦力
譯文內容由第三人軟體翻譯。